A nest of syriQ BioPure® 5.5 ml large-volume staked-needle glass syringes held above a tub

syriQ BioPure® 5.5 ml

The first large-volume staked-needle glass syringe for biologics​
Level up now!

Product features of syriQ BioPure® 5.5 ml

The latest addition to the syriQ BioPure® platform for biologics. Learn more about the world's first large-volume staked-needle glass syringe, which combines the highest quality with a proven design to offer high compatibility while putting the patient's needs first.


Female laboratory technician examining a large-volume glass syringe

Highest quality​

Part of the award-winning* syriQ BioPure® family, this large-volume 5.5 ml syringe ​provides superior functionality and increased stability of sensitive drug​ products​​.

*Pharmapack Europe Award Winner 2019 for ‘Best Innovation in Packaging Material & Component’.

Proven design

The syriQ BioPure® 5.5 ml syringe consists of a traditional staked-needle and container ​closure, along with a plunger rod and finger grip to enable the syringe to be used without a device in pre-clinical testing ​and formulation development. In addition, large-volume subcutaneous injection ​can also reduce waste through fewer injections and lower ​complexity.

Strong compatibility

The latest member of the ready-to-use (RTU) ​SCHOTT iQ® family offers general compatibility with existing filling lines​.

Patient-centric

The large-volume design results in fewer injections, reduces treatment burden, ​and gets patients out of the clinic and into their homes by supporting the transition from​ intravenous to subcutaneous injection. ​

Highest quality​

Proven design

Strong compatibility

Patient-centric

Compatibility benefits

The first large-volume staked-needle glass syringe has been designed for subcutaneous delivery ​with devices such as autoinjectors and has been verified to work with a plunger from renowned manufacturer Datwlyer. The benefits of the syriQ BioPure® 5.5 ml syringe are: ​​

syriq-biopure-large-volume_text-image-slider-01

  • It answers the trend of higher volumes in the drug delivery industry​.
  • It enables the transition from intravenous to subcutaneous delivery to offer new development options to pharma companies​.
  • It offers the option of large-volume biologics injection at home by supporting ​the transition from hospital administration by health care professionals ​to self-management or self-injection in the comfort of a patient’s own home.​
syriQ BioPure® 5.5 ml prefilled glass syringes are compatible with ​the YpsoMate® 5.5 autoinjector*, an automated injection device suitable for all patient groups.​ ​

*YpsoMate® is a brand from the Ypsomed Group.
syriq-biopure-large-volume_text-image-slider-02

The NeoFlex™ plunger* for large-volume biologics from Datwyler ​has been verified with the syriQ BioPure® 5.5 ml prefilled glass syringe system.​

*NeoFlex™ plunger is a brand from Datwyler Pharma Packaging.

Get in touch with syriQ BioPure® 5.5 ml​

Isabelle Jeangoudoux

Isabelle Jeangoudoux

Head of Global Product Management​ Glass Syringes​

*Field is required

SCHOTT Pharma will use your data only for reacting to your inquiry. Find more information about processing your personal data in SCHOTT Pharma’s data privacy policy

 

I agree that SCHOTT Pharma AG & Co. KGaA may send me e-mails with information on products and services of SCHOTT Pharma. My data will not be passed on to third parties. After registration, I can revoke my consent at any time at the SCHOTT Subscription Center following the link in each email footer.